Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

5articles mentioning drugs

12drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: imiquimod ×

imiquimod

This drug is selected. Its supporting articles are shown below.

Articles mentioning imiquimod

5 articles · page 1 of 1

Pre-existing infiltration with T cells and CD14+ myeloid cells is associated with treatment response to imiquimod in primary and recurrent vulvar high-grade squamous intraepithelial lesions

jitc · abstract · 2025-10-20 · 7 matching annotations

99.5%

imiquimod vHSIL ClinicalTrials.gov vulvar high-grade squamous intraepithelial lesions

…and this was also reflected by their clinical responsiveness to imiquimod. Higher numbers of intraepithelial CD3+CD8-(CD4+) T helper cell…

1004 ABS001: a retention-optimized intratumoral immunotherapy eliciting robust innate and adaptive responses in HPV and non-HPV tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

93.8%

ABS001 imiquimod Cervical cancer

…y was conducted using low-, mid-, and high-dose formulations of ABS001 to explore potential bell-shaped immunologic effects.Results In…

PO:01:009 Hyperlipidemia promotes neutrophil extracellular trap formation following methylprednisolone pulse in lupus mice

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

80.7%

Methylprednisolone imiquimod IMQ SLE ONFH systemic lupus erythematosus osteonecrosis of the femoral head (ONFH)Hyperlipidemia

…Objectives Methylprednisolone (mPSL) pulse therapy is an essential treatment for systemic lup…

PT6:04 Hyperlipidemia exacerbates methylprednisolone pulse-induced osteonecrosis of the femoral head in lupus mice

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

84.1%

Methylprednisolone imiquimod SLE ONFH hyperlipidemia systemic lupus erythematosus mPSL pulse therapy

…Objectives Methylprednisolone (mPSL) pulse therapy is an essential treatment for systemic lup…

Effect of medical-grade honey (L-Mesitran) for cervical intraepithelial neoplasia II: protocol for a multicentre cohort pilot study (HONEY FOR CIN II study)

bmjopen · abstract · 2025-07-24 · 1 matching annotations

88.5%

imiquimod MGH L-Mesitran Soft Zuyderland Medical Centre CIN II expectant management CIN III Maastricht University Medical Centre+High-grade squamous intraepithelial lesions Zuyderland Medical Centre Heerlen

… CIN II include large loop excision of the transformation zone, imiquimod and expectant management. Each treatment option has its drawbac…